Is Telix Pharmaceuticals Limited (TLX) a Buy, Sell, or Hold?
NASDAQ : TLX
Telix Pharmaceuticals Limited — Competitors
$9.96 USD
-$0.26 (-2.54%)
- Volume
- 56.54K
- Average Volume
- 164.86K
- Market Capitalization
- $3.37B
- P/E Ratio
- -444.86
- Dividend Yield
- 0.00%
- Price Target
- $18.00
- Year High
- $14.27
- Year Low
- $6.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.43
TLX vs. The Competition
| Properties | TLX | ACAD | ADMA | BLTE |
|---|---|---|---|---|
| Market Cap | $3.37B | $4.35B | $1.96B | $6.36B |
| Shares Outstanding | $338.78M | $171.24M | $231.77M | $40.09M |
| P/E Ratio | -444.86 | 11.4 | 12.28 | -62.17 |
| EPS | -0.03 | 2.2 | 0.7 | -2.26 |
| Day Low | 9.915 | 25.04 | 8.36 | 153.88 |
| Day High | 10.32 | 25.55 | 8.48 | 159.23 |
| Year Low | 6.28 | 19.69 | 7.21 | 60 |
| Year High | 14.27 | 28.35 | 20.458 | 200 |
| Average Price 50 | 10.3536 | 23.1684 | 8.4748 | 146.7415 |
| Average Price 200 | 9.30078 | 23.50145 | 13.49013 | 148.09923 |
| Volume | 56539.58 | 225.32K | 365.43K | 49161 |
| Average Volume | - | - | - | - |